<p>D384 cells were treated with 0, 5, 10, 15 and 20 μM DhL for 6 h, 16 h and 32 h, visualized under microscope and imaged. Magnification: 40X.</p
<p>(A) Cellular morphological changes in U87MG and U373MG cell lines were done in a dose-dependent m...
<p>HeLa cells and HMDM were respectively incubated for 6 h with 200 µg/mL LDL (A) or 50 µg/ml AcLDL ...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
<p>(A). The chemical structure of DhL (B). Analysis of D384 cell viability upon DhL exposure using a...
<p>Unsynchronized HeLa (A) and MCF-7 cells (B) and synchronized HeLa (C and D) cells were treated wi...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p>Cell cycle analysis. D384 cells were exposed to 0 (C-, control), 5, 7.5 and 10 μM of DhL for 6, 1...
<p>Synchronized HeLa cells treated with 0–20 µM DhL for 48 h were analyzed for: (A) protein concentr...
<p>Apoptotic D384 cells were detected and monitored by Annexin V-FITC/PI staining. (A) A representat...
Cellular morphology of HL-60 and MOLM-16 treated with various concentrations of FD268 at 48 h. Phase...
<p>D384 cells were exposed to 12.5, 15 and 17.5 μM DhL for 16 h. Total protein lysates were separate...
<p>Synchronized HeLa cells were treated with 0, 10, or 20 µM DhL and analyzed by phase contrast in l...
<p>(A) Hela cells were loaded with 200 µg/ml LDL for 24 h. Cells were then treated for 6 h with 80 µ...
<p>A, Morphological changes of SW620 cells observed under phase-contrast microscopy (100 × magnifica...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>(A) Cellular morphological changes in U87MG and U373MG cell lines were done in a dose-dependent m...
<p>HeLa cells and HMDM were respectively incubated for 6 h with 200 µg/mL LDL (A) or 50 µg/ml AcLDL ...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
<p>(A). The chemical structure of DhL (B). Analysis of D384 cell viability upon DhL exposure using a...
<p>Unsynchronized HeLa (A) and MCF-7 cells (B) and synchronized HeLa (C and D) cells were treated wi...
<p>(A) Synchronized HeLa cells were treated with 0–20 µM DhL for 72 h and subjected to DNA flow cyto...
<p>Cell cycle analysis. D384 cells were exposed to 0 (C-, control), 5, 7.5 and 10 μM of DhL for 6, 1...
<p>Synchronized HeLa cells treated with 0–20 µM DhL for 48 h were analyzed for: (A) protein concentr...
<p>Apoptotic D384 cells were detected and monitored by Annexin V-FITC/PI staining. (A) A representat...
Cellular morphology of HL-60 and MOLM-16 treated with various concentrations of FD268 at 48 h. Phase...
<p>D384 cells were exposed to 12.5, 15 and 17.5 μM DhL for 16 h. Total protein lysates were separate...
<p>Synchronized HeLa cells were treated with 0, 10, or 20 µM DhL and analyzed by phase contrast in l...
<p>(A) Hela cells were loaded with 200 µg/ml LDL for 24 h. Cells were then treated for 6 h with 80 µ...
<p>A, Morphological changes of SW620 cells observed under phase-contrast microscopy (100 × magnifica...
<p>Unsynchronized (A) and synchronized (B) HeLa cells were treated with 0, 20, or 30 µM DhL for 24 o...
<p>(A) Cellular morphological changes in U87MG and U373MG cell lines were done in a dose-dependent m...
<p>HeLa cells and HMDM were respectively incubated for 6 h with 200 µg/mL LDL (A) or 50 µg/ml AcLDL ...
<p>(A) Synchronized HeLa cells treated with 0–20 µM of DhL were lysed at the indicated times. Immuno...
DOI
Add to ORKG